JP Morgan Chase
DVAX

JP Morgan Chase’s Dynavax Technologies DVAX Stock Holding History

JP Morgan Chase’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-674,643
Closed -$10.4M – 7622
2025
Q4 		$10.4M Sell
674,643
-296,132
-31% -$3.26M ﹤0.01% 2647
2025
Q3 		$9.64M Buy
970,775
+27,941
+3% +$291K ﹤0.01% 2746
2025
Q2 		$9.35M Buy
942,834
+6,461
+0.7% +$68.1K ﹤0.01% 2620
2025
Q1 		$12.1M Buy
936,373
+402,779
+75% +$5.33M ﹤0.01% 2372
2024
Q4 		$6.81M Buy
533,594
+328,147
+160% +$3.97M ﹤0.01% 3063
2024
Q3 		$2.29M Buy
205,447
+1,267
+0.6% +$14K ﹤0.01% 3895
2024
Q2 		$2.29M Sell
204,180
-316,105
-61% -$3.68M ﹤0.01% 3659
2024
Q1 		$6.46M Sell
520,285
-121,453
-19% -$1.58M ﹤0.01% 2870
2023
Q4 		$8.97M Buy
641,738
+381,124
+146% +$5.29M ﹤0.01% 2591
2023
Q3 		$3.85M Buy
260,614
+1,749
+0.7% +$24.6K ﹤0.01% 3033
2023
Q2 		$3.34M Buy
258,865
+47,444
+22% +$541K ﹤0.01% 3166
2023
Q1 		$2.07M Buy
211,421
+38,374
+22% +$410K ﹤0.01% 3515
2022
Q4 		$1.84M Buy
173,047
+19,236
+13% +$224K ﹤0.01% 3621
2022
Q3 		$1.61M Buy
153,811
+12,241
+9% +$159K ﹤0.01% 3650
2022
Q2 		$1.78M Buy
141,570
+58,671
+71% +$623K ﹤0.01% 3641
2022
Q1 		$898K Sell
82,899
-26,022
-24% -$316K ﹤0.01% 4348
2021
Q4 		$1.53M Buy
108,921
+43,203
+66% +$711K ﹤0.01% 4047
2021
Q3 		$1.26M Sell
65,718
-36
-0.1% -$478 ﹤0.01% 4133
2021
Q2 		$648K Buy
65,754
+2,890
+5% +$26.3K ﹤0.01% 4540
2021
Q1 		$618K Buy
62,864
+15,036
+31% +$124K ﹤0.01% 4547
2020
Q4 		$212K Buy
47,828
+8,219
+21% +$37.2K ﹤0.01% 4789
2020
Q3 		$174K Buy
39,609
+9,528
+32% +$68K ﹤0.01% 4425
2020
Q2 		$267K Buy
30,081
+2,734
+10% +$13.8K ﹤0.01% 4135
2020
Q1 		$97K Buy
27,347
+25
+0.1% +$116 ﹤0.01% 4520
2019
Q4 		$156K Sell
27,322
-1,754
-6% -$9.38K ﹤0.01% 4759
2019
Q3 		$104K Buy
29,076
+9,102
+46% +$35.3K ﹤0.01% 4891
2019
Q2 		$77K Sell
19,974
-249,566
-93% -$1.45M ﹤0.01% 5015
2019
Q1 		$1.97M Sell
269,540
-1,035
-0.4% -$10.1K ﹤0.01% 3343
2018
Q4 		$2.48M Buy
270,575
+5,906
+2% +$65.4K ﹤0.01% 3127
2018
Q3 		$3.28M Buy
264,669
+4,591
+2% +$62.1K ﹤0.01% 3091
2018
Q2 		$3.97M Sell
260,078
-4,703
-2% -$81.3K ﹤0.01% 2863
2018
Q1 		$5.26M Sell
264,781
-68,000
-20% -$1.17M ﹤0.01% 2538
2017
Q4 		$6.22M Sell
332,781
-74,157
-18% -$1.49M ﹤0.01% 2496
2017
Q3 		$8.65M Sell
406,938
-98,289
-19% -$1.56M ﹤0.01% 2109
2017
Q2 		$4.88M Buy
505,227
+391,632
+345% +$2.54M ﹤0.01% 2486
2017
Q1 		$675K Sell
113,595
-24,420
-18% -$117K ﹤0.01% 3583
2016
Q4 		$546K Buy
138,015
+2,615
+2% +$19.2K ﹤0.01% 3725
2016
Q3 		$1.42M Buy
+135,400
New +$1.95M ﹤0.01% 2975
2016
Q2 		– Sell
-62,400
Closed -$1.2M – 4816
2016
Q1 		$1.2M Sell
62,400
-4,558
-7% -$92.1K ﹤0.01% 2987
2015
Q4 		$1.62M Sell
66,958
-10,842
-14% -$272K ﹤0.01% 2865
2015
Q3 		$1.91M Buy
+77,800
New +$2.2M ﹤0.01% 2768
2014
Q1 		– Sell
-1,180
Closed -$23K – 3664
2013
Q4 		$23K Sell
1,180
-12,143
-91% -$178K ﹤0.01% 4011
2013
Q3 		$158K Sell
13,323
-14,002
-51% -$176K ﹤0.01% 4099
2013
Q2 		$300K Buy
+27,325
New +$576K ﹤0.01% 3822

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's DVAX Position: Q1 2026 in Review

JP Morgan Chase sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 674,643 shares — an estimated $10.4M sold.

JP Morgan Chase first reported a position in DVAX in Q2 2013 and held it in 44 quarters. The position peaked at $12.1M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • JP Morgan Chase reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 674,643 Dynavax Technologies shares in Q1 2026, an estimated $10.4M.
  • JP Morgan Chase first reported a position in Dynavax Technologies in Q2 2013 and held it in 44 quarters.
  • JP Morgan Chase's Dynavax Technologies position peaked at $12.1M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.